# Nexus Pharmaceuticals, LLC – FDA Inspection, May 25, 2022

Source: https://www.keypedia.com/records/fda_inspections/nexus-pharmaceuticals-llc/d820ab6f-59c0-4bda-89aa-27937437a5f9
Source feed: FDA_Inspections

> FDA inspection 1171206 of Nexus Pharmaceuticals, LLC, May 25, 2022. Classification: No Action Indicated (NAI). 6 other FDA inspections on record for this company.

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1171206
- Company Name: Nexus Pharmaceuticals, LLC
- Inspection Date: 2022-05-25
- Classification: No Action Indicated (NAI)
- Classification Code: NAI
- Project Area: Drug Quality Assurance
- Product Type: Drugs
- Center: Human Drugs
- Office Name: Center for Drug Evaluation and Research
- Citation Count: 0

## Related Documents

- [FDA Inspection 1301896 - 2026-06-04](https://www.keypedia.com/records/fda_inspections/nexus-pharmaceuticals-llc/50e8e103-ce27-4d4c-aafe-99c6b6c73b6f)
- [FDA Inspection 1224257 - 2023-11-07](https://www.keypedia.com/records/fda_inspections/nexus-pharmaceuticals-llc/a46209ec-71b6-4f0f-9768-09461ae4c6c0)
- [FDA Inspection 976279 - 2016-06-29](https://www.keypedia.com/records/fda_inspections/nexus-pharmaceuticals-llc/e3895940-f539-423b-9d7e-f21274a06b35)
- [FDA Inspection 903661 - 2014-11-05](https://www.keypedia.com/records/fda_inspections/nexus-pharmaceuticals-llc/32cc3842-5652-47d9-ae6e-69f963728a59)
- [FDA Inspection 871664 - 2014-03-28](https://www.keypedia.com/records/fda_inspections/nexus-pharmaceuticals-llc/a9f75950-966b-48b2-84d8-3c82a857af61)

Company: https://www.keypedia.com/companies/nexus-pharmaceuticals-llc/9f6c2dd9-2ee0-4492-bcaf-992ff47330cf

Office: https://www.keypedia.com/offices/center-for-drug-evaluation-and-research/cd980d74-1cbf-4226-ba9a-9045324c236c